Crossmark

The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances

Crossref DOI link: https://doi.org/10.1186/s40164-024-00583-7

Published Online: 2024-12-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yao, Pin

Liu, Ya-Guang

Huang, Gang

Hao, Liangchun

Wang, Runan
Funding

Funding for this research was provided by:

Key R&D GuidancePlan Projects of Liaoning Province. (2020JH1/10300001)
License Information

Text and Data Mining valid from 2024-12-04

Version of Record valid from 2024-12-04
More Information

Article History

Received: 16 May 2024

Accepted: 18 November 2024

First Online: 4 December 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below